Cargando…

Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach

Inflammatory bowel diseases (IBD) belong to the group of immune-mediated diseases (IMIDs). The effect of associated IMIDs in the prognosis in IBD is nowadays unknown. To describe IMIDs associated to IBD patients and evaluate differences linked to the presence or absence of IMIDs. A unicentric retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	García, M. J., Pascual, M., Del Pozo, C., Díaz-González, A., Castro, B., Rasines, L., Crespo, J., Rivero, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330038/ https://www.ncbi.nlm.nih.gov/pubmed/32612137 http://dx.doi.org/10.1038/s41598-020-67710-2

Ejemplares similares

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
por: Jiang, Yan, et al.
Publicado: (2021)

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe
por: Arias-Loste, Maria Teresa, et al.
Publicado: (2012)

Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
por: Papamichael, Konstantinos, et al.
Publicado: (2023)

Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
por: Akiyama, Shintaro, et al.
Publicado: (2022)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
por: Wen, Zhonghui, et al.
Publicado: (2004)

Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications
por: Vernia, Filippo, et al.
Publicado: (2022)

Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
por: Sewell, Gavin W, et al.
Publicado: (2022)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023)

Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
por: Otte, Megan Lynn, et al.
Publicado: (2023)

Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
por: Bezzio, Cristina, et al.
Publicado: (2022)

Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
por: Saez, Angela, et al.
Publicado: (2023)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021)

m(6)A Modification Mediates Mucosal Immune Microenvironment and Therapeutic Response in Inflammatory Bowel Disease
por: Chen, Yongyu, et al.
Publicado: (2021)

Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy
por: García, María José, et al.
Publicado: (2022)

Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease
por: Weingarden, Alexa R, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Lee, Shona J., et al.
Publicado: (2014)

Implications of Antioxidant Systems in Inflammatory Bowel Disease
por: Guan, Guiping, et al.
Publicado: (2018)

Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021)

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2021)

The Unfolded Protein Response and Its Implications for Novel Therapeutic Strategies in Inflammatory Bowel Disease
por: Verjan Garcia, Noel, et al.
Publicado: (2023)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
por: Fan, Fei-Yan, et al.
Publicado: (2017)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease
por: Bryan, Phillips-Farfán, et al.
Publicado: (2016)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Cardiovascular implications of inflammatory bowel disease: An updated review
por: Bhardwaj, Arshia, et al.
Publicado: (2023)

Hepatobiliary manifestations in inflammatory bowel disease: A practical approach
por: Núñez F, Paulina, et al.
Publicado: (2022)

Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies
por: García-Serrano, Cristina, et al.
Publicado: (2020)

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
por: Hong, Sung Noh
Publicado: (2017)

Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
por: Liu, Yulan, et al.
Publicado: (2017)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017)

Nutritional approach as therapeutic manipulation in inflammatory bowel disease
por: Yoon, Jin Young
Publicado: (2019)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
por: Xu, Qiuyun, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jgjd74mak398hbs7pe4d2i25g